WESSEL; Matthew David
Patent Applications and Registrations
Patent applications and USPTO patent grants for WESSEL; Matthew David.The latest application filed is for "pharmaceutical compositions for the treatment of hbv".
- WESSEL; Matthew David - Sisters OR
- Wessel; Matthew David - Siters OR
- Wessel; Matthew David - Ledyard CT
| Patent | Date |
|---|---|
| Pharmaceutical Compositions For The Treatment Of Hbv App 20220241208 - ARNOLD; Lee D. ; et al. | 2022-08-04 |
| IRAK inhibitors and uses thereof Grant 9,790,234 - Romero , et al. October 17, 2 | 2017-10-17 |
| Irak Inhibitors And Uses Thereof App 20170081340 - Romero; Donna L. ; et al. | 2017-03-23 |
| IRAK inhibitors and uses thereof Grant 9,481,687 - Romero , et al. November 1, 2 | 2016-11-01 |
| Irak Inhibitors And Uses Thereof App 20160296524 - Romero; Donna L. ; et al. | 2016-10-13 |
| Irak Inhibitors And Uses Thereof App 20160193216 - Harriman; Geraldine C. ; et al. | 2016-07-07 |
| IRAK inhibitors and uses thereof Grant 9,340,554 - Romero , et al. May 17, 2 | 2016-05-17 |
| Irak Inhibitors And Uses Thereof App 20160002257 - Romero; Donna L. ; et al. | 2016-01-07 |
| IRAK inhibitors and uses thereof Grant 9,212,190 - Harriman , et al. December 15, 2 | 2015-12-15 |
| IRAK inhibitors and uses thereof Grant 9,085,586 - Romero , et al. July 21, 2 | 2015-07-21 |
| Irak Inhibitors And Uses Thereof App 20150025093 - Romero; Donna L. ; et al. | 2015-01-22 |
| IRAK inhibitors and uses thereof Grant 8,703,941 - Romero , et al. April 22, 2 | 2014-04-22 |
| Irak Inhibitors And Uses Thereof App 20140018361 - Harriman; Geraldine C. ; et al. | 2014-01-16 |
| Irak Inhibitors And Uses Thereof App 20140018343 - Romero; Donna L. ; et al. | 2014-01-16 |
| Irak Inhibitors And Uses Thereof App 20130231328 - Harriman; Geraldine C. ; et al. | 2013-09-05 |
| Irak Inhibitors And Uses Thereof App 20120283238 - Romero; Donna L. ; et al. | 2012-11-08 |
| Isothiazole derivatives useful as anticancer agents Grant 7,276,602 - Lippa , et al. October 2, 2 | 2007-10-02 |
| Isothiazole derivatives useful as anticancer agents App 20040152691 - Lippa, Blaise ; et al. | 2004-08-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 